Bengenin
Bergenin, a polyphenol, is a potent antinarcotic agent with antioxidant action. (In Vitro) :Bergenin (7.5-30μM; 24 hours) decreases the viability of HeLa cervical cancer cells (IC50=15 μM) .Bergenin (7.5-30 μM; 24 hours) induces apoptosis in HeLa cervical cancer cells. (In Vivo) :Pretreatment with Bergenin (12.5-100 mg/kg; i.p.; once) produces a dose-related inhibition of acetic acid-induced writhing in mice.
Product Specifications
CAS Number
477-90-7
Product Name Alternative
(–) -Bergenin | Cuscutin | NSC 661749
Purity
>98% (HPLC)
Solubility
DMSO: 66 mg/mL (201.05 mM)
Smiles
COC1=C (C=C2C (=C1O) [C@H]3[C@@H] ([C@H] ([C@@H] ([C@H] (O3) CO) O) O) OC2=O) O
Molecular Formula
C14H16O9
Molecular Weight
328.27
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
373905-01 20 µg
KCNJ1, Recombinant, Human, aa178-391, His-Tag (ATP-sensitive Inward Rectifier Potassium Channel 1)
Sign In for Pricing
View Details 373905-02 100 µg
KCNJ1, Recombinant, Human, aa178-391, His-Tag (ATP-sensitive Inward Rectifier Potassium Channel 1)
Sign In for Pricing
View Details 
MBS1064236-01 0.02 mg (E-Coli)
Recombinant Streptomyces glaucescens Tetracenomycin polyketide synthesis hydroxylase tcmH (tcmH)
Sign In for Pricing
View Details MBS1064236-02 0.1 mg (E-Coli)
Recombinant Streptomyces glaucescens Tetracenomycin polyketide synthesis hydroxylase tcmH (tcmH)
Sign In for Pricing
View Details